Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 207

2.

Stabilization of the retinoblastoma protein by A-type nuclear lamins is required for INK4A-mediated cell cycle arrest.

Nitta RT, Jameson SA, Kudlow BA, Conlan LA, Kennedy BK.

Mol Cell Biol. 2006 Jul;26(14):5360-72.

3.

Profiles of the 2 INK4a gene products, p16 and p14ARF, in human reference urothelium and bladder carcinomas, according to pRb and p53 protein status.

Le Frère-Belda MA, Gil Diez de Medina S, Daher A, Martin N, Albaud B, Heudes D, Abbou CC, Thiery JP, Zafrani ES, Radvanyi F, Chopin D.

Hum Pathol. 2004 Jul;35(7):817-24.

PMID:
15257544
4.

p16/p14(ARF) cell cycle regulatory pathways in primary neuroblastoma: p16 expression is associated with advanced stage disease.

Omura-Minamisawa M, Diccianni MB, Chang RC, Batova A, Bridgeman LJ, Schiff J, Cohn SL, London WB, Yu AL.

Clin Cancer Res. 2001 Nov;7(11):3481-90.

5.

A-type lamins regulate retinoblastoma protein function by promoting subnuclear localization and preventing proteasomal degradation.

Johnson BR, Nitta RT, Frock RL, Mounkes L, Barbie DA, Stewart CL, Harlow E, Kennedy BK.

Proc Natl Acad Sci U S A. 2004 Jun 29;101(26):9677-82. Epub 2004 Jun 21.

6.

Deregulation of the TP53/p14ARF tumor suppressor pathway in low-grade diffuse astrocytomas and its influence on clinical course.

Watanabe T, Katayama Y, Yoshino A, Komine C, Yokoyama T.

Clin Cancer Res. 2003 Oct 15;9(13):4884-90.

7.

Mdm2 overexpression and p14(ARF) inactivation are two mutually exclusive events in primary human lung tumors.

Eymin B, Gazzeri S, Brambilla C, Brambilla E.

Oncogene. 2002 Apr 18;21(17):2750-61.

8.

Retinoblastoma protein modulates gankyrin-MDM2 in regulation of p53 stability and chemosensitivity in cancer cells.

Qiu W, Wu J, Walsh EM, Zhang Y, Chen CY, Fujita J, Xiao ZX.

Oncogene. 2008 Jul 3;27(29):4034-43. doi: 10.1038/onc.2008.43. Epub 2008 Mar 10.

PMID:
18332869
9.

Different combinations of genetic/epigenetic alterations inactivate the p53 and pRb pathways in invasive human bladder cancers.

Sarkar S, Jülicher KP, Burger MS, Della Valle V, Larsen CJ, Yeager TR, Grossman TB, Nickells RW, Protzel C, Jarrard DF, Reznikoff CA.

Cancer Res. 2000 Jul 15;60(14):3862-71.

10.

Growth suppression by a p14(ARF) exon 1beta adenovirus in human tumor cell lines of varying p53 and Rb status.

Saadatmandi N, Tyler T, Huang Y, Haghighi A, Frost G, Borgstrom P, Gjerset RA.

Cancer Gene Ther. 2002 Oct;9(10):830-9.

11.

ARF regulates the stability of p16 protein via REGγ-dependent proteasome degradation.

Kobayashi T, Wang J, Al-Ahmadie H, Abate-Shen C.

Mol Cancer Res. 2013 Aug;11(8):828-33. doi: 10.1158/1541-7786.MCR-13-0207. Epub 2013 Jul 1.

12.

Alterations of the p16-pRb pathway and the chromosome locus 9p21-22 in non-small-cell lung carcinomas: relationship with p53 and MDM2 protein expression.

Gorgoulis VG, Zacharatos P, Kotsinas A, Liloglou T, Kyroudi A, Veslemes M, Rassidakis A, Halazonetis TD, Field JK, Kittas C.

Am J Pathol. 1998 Dec;153(6):1749-65.

13.
14.

P16(INK4A) is implicated in both the immediate and adaptative response of human keratinocytes to UVB irradiation.

Chazal M, Marionnet C, Michel L, Mollier K, Dazard JE, Della Valle V, Larsen CJ, Gras MP, Basset-Séguin N.

Oncogene. 2002 Apr 18;21(17):2652-61.

15.

ARF promotes accumulation of retinoblastoma protein through inhibition of MDM2.

Chang DL, Qiu W, Ying H, Zhang Y, Chen CY, Xiao ZX.

Oncogene. 2007 Jul 12;26(32):4627-34. Epub 2007 Feb 5.

PMID:
17297463
17.

Alterations of the p16(INK4) locus in human malignant mesothelial tumors.

Hirao T, Bueno R, Chen CJ, Gordon GJ, Heilig E, Kelsey KT.

Carcinogenesis. 2002 Jul;23(7):1127-30.

PMID:
12117769
18.
19.

Immunohistochemical inactivation of p14ARF concomitant with MDM2 overexpression inversely correlates with p53 overexpression in oral squamous cell carcinoma.

Sano T, Hikino T, Xue Q, Saito T, Kashiwabara K, Oyama T, Nakajima T.

Pathol Int. 2000 Sep;50(9):709-16.

PMID:
11012984
20.

Cyclin G1 has growth inhibitory activity linked to the ARF-Mdm2-p53 and pRb tumor suppressor pathways.

Zhao L, Samuels T, Winckler S, Korgaonkar C, Tompkins V, Horne MC, Quelle DE.

Mol Cancer Res. 2003 Jan;1(3):195-206.

Supplemental Content

Support Center